-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LMUo2QXLBQNJlPn5+wgeXNL/jkgVgZFF0HAQodJwF/S1+jUMSXVvR0bStf7dBDz6
 oyiHzc7HbKL31e99KSePQg==

<SEC-DOCUMENT>0001193125-10-286631.txt : 20101222
<SEC-HEADER>0001193125-10-286631.hdr.sgml : 20101222
<ACCEPTANCE-DATETIME>20101222160602
ACCESSION NUMBER:		0001193125-10-286631
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20101221
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20101222
DATE AS OF CHANGE:		20101222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		101268796

	BUSINESS ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): December&nbsp;22, 2010 (December 21, 2010) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>ARCA biopharma, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name of Registrant as Specified in Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-22873</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>36-3855489</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or Other Jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8001 Arista Place, Suite 200,
Broomfield, CO 80021 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of Principal Executive Offices) (Zip Code) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(720) 940-2200 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Registrant&#146;s Telephone Number, Including Area Code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not
Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former Name or Former Address, if Changed Since Last Report) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;1.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;21, 2010, ARCA biopharma, Inc. (&#147;ARCA&#148;) and the University of Cincinnati agreed to extend the term of the Exclusive Option
Agreement dated December&nbsp;2, 2009 (filed as Exhibit 10.27 to the Company&#146;s Annual Report on Form 10-K for the period ended December&nbsp;31, 2009), as amended, that gave ARCA an option to license exclusive, worldwide rights to certain
patent rights relating to genetic polymorphisms of adrenergic cardiac receptors.&nbsp;The rights include those for developing and commercializing diagnostics for the receptor polymorphisms that may indicate which patients will respond most favorably
to Gencaro. The period of the option has been extended to January&nbsp;31, 2011.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The letter in regard to the agreement term extension is filed
as Exhibit 10.1 to this Current Report on Form 8-K, and the description of the extension is qualified in its entirety by reference to such exhibit. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, dated December 21, 2010, of the Exclusive Option Agreement dated December 2, 2009, as amended, between ARCA biopharma, Inc. and the
University of Cincinnati.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: December&nbsp;21, 2010 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA biopharma, Inc.</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(Registrant)</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: Senior Vice President and General Counsel</FONT></TD></TR></TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, dated December&nbsp;21, 2010, of the Exclusive Option Agreement dated December&nbsp;2, 2009, as amended, between ARCA biopharma,
Inc. and the University of Cincinnati.</FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dex101.htm
<DESCRIPTION>LETTER IN REGARD TO AGREEMENT TERM EXTENSION
<TEXT>
<HTML><HEAD>
<TITLE>Letter in regard to agreement term extension</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 10.1 </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g129956g84g64.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>8001 Arista Place, Suite 200 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Broomfield, CO 80021 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Phone: 720-940-2200, Fax: 720-208-9261
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">December&nbsp;21, 2010 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Pinski </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director of Intellectual Property </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">University of Cincinnati </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Office of Intellectual
Property </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 Goodman Dr, Suite 240 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cincinnati, Ohio 45219-0829 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Geoffrey,
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">When countersigned by the University of Cincinnati, this letter will extend the Exclusive Option Agreement between ARCA
biopharma, Inc. and the University of Cincinnati dated December&nbsp;2, 2009 to January&nbsp;31, 2011. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please sign below
indicating your agreement to the above. Feel free to contact me if you have any questions </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Best regards,</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">SVP and General Counsel</FONT></TD></TR></TABLE></DIV> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>ACCEPTED AND AGREED</U>:</FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">UNIVERSITY OF CINCINNATI</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Geoffrey Pinski</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Geoffrey Pinski, Director, OEATC</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December 21, 2010</FONT></P></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g129956g84g64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g129956g84g64.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`:P$A`P$1``(1`0,1`?_$`,P```$$`@,!`0``````
M```````'"`D*!`8"`P4+`0$!```&`P$```````````````$#!`8'"`(%"@D0
M``$$`0,#`@(&"`,#"0D```$"`P0%!@`1!R$2"#$3%`E!42(RE!5A<:'14B,6
M"H%",Y$D%\%B0S0E)K8X>/"Q\52DU#=W&1$``@$#`@0"!0<&"P4)``````$"
M$0,$!08A,1('05%A<3(3")&AT2)2(Q3P@;%"LG/A\6*"TF/3)!46"<&BPC0E
M,T-31&24-448_]H`#`,!``(1`Q$`/P"][GW(&.<;X[/RK+;-JIIZ_;O>7VK<
MDON'LC08<<`NRYTM9V;;1U)]2!N19._.X.V>V>@7=T;OOQL:1;X)JKDY>27B
MWP*_3=-R=3R%B8J<[TWPIX>OT$7'(7G]R):6$B/QW55F+4Z"MJ-,LH;5[>R0
M%%*9+K2R*R'W@;A`0Z`#U.^^OE+W*_U$-X:OJ%_%[98\=/TN,G"U?N6K5V=R
M2YRE&\IJ*2<:?52?$SYHW9_!Q<:&1K4O?W;B]A2<5'TOIH_5Q$UC>8/DO+22
MWG44;)4HD8IBQ.R.JSV_DX([1Z].FL++XU_BFOV9+&UVR[T$VZ8&`Z)<>7X<
MN:';#948.5W%;:_K;O\`3/13Y8^3"D)5_7C/0E*^W$\3`![5?>*ZC8;*`U,_
M_:7Q39-R5K&UVVI+I7_Q^`^+]>.4M[MKLN"ZXXS4/WMW^F>A-\I_)>)+D1CG
M30]EU2.N(XL=O0C?_LCJ0#KL-0^,;XJ-.U2>%>UR'W?"2_P_`]JB?/\`#^E$
MJ&P-B.";Q77]]=_IGB/^7?DRRU[J\YC(0A;C)5_2>+$N.-=JEG8U&R>U*Q_M
MUUC^-?XGK=JF3N&%N[)OI_Z=@4?H?]VX4)T.W^Q/96%*3?\`77N'^^>YB?GC
MS=2S&EY)_3^8UI6@/1957%HYQ0%#W/8GU:&8Z'"C?M[V5`'UU?&TO]0'O=HE
M^%O=L</5\1S75-6[%F:CXM1LQMU=.2H4&=VAT;+LR>FQE9O=+Z?KREQ\*J39
M)KPQSSB'-U"[;8V^_"L*\LMWF/V/LHM*I][_`$PM*/L28;W4-OMDH6>G0C;7
MU,[+]^=H=[M(EJ&U[B_Q*U!>]QI.DX2XU:\6O36A@G<VV-3VKD_A]0@W"7LS
M7+\D+2'7-A]K]B?^0:SE"49Q4X.L7XEMI-*C=7Y^8>ZY_%^Q/[M<B(>ZY_%^
MQ/[M`'NN?Q?L3^[0&J9MR!B'&F-6>9\A99CN%8A3-QW+;)\IMH5)258E2FX<
M95A8SUQXL=,F7(;:;W4-U'UWT!L42P;G1V9<60S(C2669,=^.XA]AZ/):0]'
M>9=1W-.,OLK2M!2I0*5`[]=`9/NN?Q?L3^[0![KG\7[$_NT!T/SV8J0J5+CQ
MDJ4E"527F&$J6K?M0E3JD!2U!)V`ZG;0'8S)$A(7'D,OH5U2MEUEU*MCL>TM
MJ4#L=`=A=4CJMQ"$@]2M3:0-O7?<C;8#0&"+JL=<2RS;5CCRCLEI$^$MQ1^@
M)0'2HGH?0:`S^][UZD>NX2""#Z$$#8@Z`X^ZY_%^CT3]'K]'T:`/=<_B_8G]
MV@#W7#Z*_8/W:``ZX3L%;D>H`3N.NWIM]>@$ZSCF;BGC%!7R/RCQY@:0CW-L
MPS''<==*/0*;8M)\5YT$_P`*3H!$8_GUX4RI)B1O+'Q\>D[A(83RGB"5!95V
M;**K,#HKZ-P?TZ`6[%.9N)LV;;7B'+'&V7AT#VUXSFN,7(6?I[4UMI*5OUVV
MV!&V@%$3([^K;J'$G?93:FW$[;`^J.X?=4#^HZ`_?=<_B_8G]V@#W7/XOV)_
M=H`]US^+]B?W:`TF7R1A4#/:GC*9FF,Q>0KZCGY-2X')MH#66V^-U;S42QOZ
MRC6^FPE5,&8Z&WGD-J0DA77[)V`W;W7/K_8/W:`/=<_B_8G]V@.2'%E203T)
M^H?NT!E:`A;\Z^3++)^5G,"8>6B@P)B*T8C;A]F;?VT-B?*F2&P2E3T.,ZVT
MWO\`<ZD?>.OB'_J`]V-9W-W'CVXQ9W+>WM)FHW80:K<O4C/JFJTZ:.*H^-$^
M!LQVCV[BX>E/5LF*EDY,:P?V4FXJOR5X#3J.BD6KB&XS1<?2DNJ8`)<=:2-W
M5-)'^HMH#<H'VB-R`=M:0X&E9NNY/O<?IEEI)*S:33G3GTUI%-+VJM5X&1[\
MUB12K*61*3ZG^JEX4^<6O#<7:9FPWI#'NQ$NI3*9]O[\-XA$Q()`5NIA2MOI
MWUGO87;W`65:SI>]Z5=C[^,N:C7ZT6O5^8M75M2OV[4U:FI2Z7R?H%5L^+32
MV4NH6@NAA;:(SP:[OCX,LM/P)2-TA*DR(BTJ!]22=_36;+_:;'TG6KUM6HR@
M[EJ<*)_>*3Y0KXKQKY\"V/\`,\KVG0C#J=R=4^*^K3S-CS[CD1LOOZUB-WO&
MP;:CM@=JW''XT?V&VQT!<><5LD?7JX^X':N,M]YVF8^-U95W.C"*2\';M?6I
MSZ>/KX,HL#7X3T^-^?5PBZ\>?%B8<@X$W534TC32#^2M(A2W$]VSUHX`_:.%
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MQ&W8C8[I[04GZTGJD_X@Z](-JY&]:C=@J0G%22\JI/\`VFF<(.W'W;YQX?(S
MEKF<@T`:`JZ_W'ODZB#BO%'B!0RTK?RR3_Q8Y2BM.#L&-4ZI57A5//2D]$65
M[\1/4E7_`,BT=MB-"9&TY*JY$H_R=_(]7DCX(\3V5K8FPS3BUAWAW-5O.=\Q
MR=A#,:+CUE*2LE[OM\/=KWRM7WW"OZ0="$X.#HR4/0X!H!M'E#XE\->8."U_
M'?-E9D-GCM1?LY/4JQK++S$;6OO&8,VM1+:L:23'<=;$.<M/LNAQHJ/<4[[:
M`J=?-@^7"KY?>/X%RSP/S=R]*XSS7+GL*GXGDV;6[E[BE\Y6S+FJE5]_4RJL
MVU3.C07VW`^PEZ.XA"N]86>T<X0<ZT\!O7RO/$K*?F*\V9AAO)'.O+6/<=\<
MX;%R_*WZ?,[ZPR'(%VEM^14V/UTJVL)L6O2ZI#KSTEQE\H:8#:4CN)T(RMN*
MJV6&+7^W\\)Y=,N'5YIY+4MX&]H^3M<PR9DQB1M]E\U\NH77.(0KJ&^Q(Z^N
MA+(2_)5_Y@'R8.=,<H,'\D\XSKB/+8\C(>.YF92K'*<(R^KJ);<>ZQ3*<+OK
M"RB4N0TC4ED/JKY$<N,R6WVEIV4E(%FSY;OG_A_GYPK*S6/4Q\.Y1PB9#Q[E
MC`(\A4QFENI<=R577='(<2),K%<G::==AK<W6TMMUE9*VRI0$B!(`)WZ`;D_
M4`-U>F_IH!(>=>=^*O&_B[).8N9,JA8?@^)QT2)EC+"G9LJ;(240*.DK&MY=
MOD=PZH-1(;25.N.$'8)"E`"IMR;\T#SY^9=S9'\=?!RHN.&,0R!Z2B-^13$0
M\\?Q>.M:)V:<F\AH;=&%T++2A[C-:ILA:A'2](>*0H"4KQV^0GXP8G"CY/Y4
M7>3>5?+$]M$G(+'*+^_@X2Q8NH0Y(;KJIJR1?7+*7@0)%I,>6ZD;EIO?M`#R
M<A^4K\N/)*=RCF>(_%,.*MI3:)=%!L\?MF"I)1WM6M38QY_NH2=TK+A/<-]`
M0.?,&^0R_P`-8ID/-OAA;9-E&/8^P_<99PQ<O?F&9U]+%9+DZVP'(8+42?D;
M-5'2IUZLDI5+4RA19<=<V00'L?VXW(4O)?%_FW#[*UM+:9AO."9[3EM/EV4E
MBKR_#*5Z$P%SW7GF(Z)=,_VH!3VJW&P(.@+$&@#0'%:D-H4XXM*$(!4M:R$I
M0A([G'%*5LE*&T`J42>@&@*'_,_S&)\_YO$+S#JK5]WC[BOE&NXVQQ##JOAI
MG!E'(EX7DX:2%J"8V1PK.RM5!)[5O/-J/W$Z`O;U\^':U\*RKI+4RMGQ(LVM
MF,**V9==,BL2H4AI>P"T/,.A0(]01H#+T!S;^^G]>@,W0$!_D=!,[R.Y4:;V
M*U9,P$A2TH"G?RBJ"1WK/:GT`Z]->=KXJ(3SOB8W;B6))7?\12XNE/[O9Y5-
MO-A_=[-P;G]0_P!N1W8=B[T60RJ0W*AR6^QUE:DEB0T\A04U):)"=PV1NE2=
M]_HU)[8[/R,.W:R+UN];RH7:^]<)4=:<(NE)5\:5*;-U9.=VS5=3Y<4/4Q;!
M86=5RY]2TQ$RV&COM*A#B6X=\QV[)LZU2D?[K.)ZR&=@DKZC;<G7T,VQL+2]
M]8%N[M^W#'W/;A][;:Z87H)5E*/A*=*UIQY&*]3UC+TO)I?3>--\).M%5\4W
MRIY<?0+)(QFME8U@]E>S(-%;4RFZR<S:R$1'9E96R2`OL<29#[T=E/:CM2>X
M'U]-9PGMW1+^B:)J.XW9Q-4P;ZC<M2<87;D5*-'T2:G)<^*31:EO-R<7(RE9
MA.Y9:K%Q3DDWZ55&T)Q['[K-K/.(TV#;,183<^OKXRD/2WK-J&ME+HBNI0M1
M9+04C;?<G5T7-J[;R-Y9/<+"OVKTX8[<;74FY7.ETI'FWP7A4HYY>9C8]O#D
MI15*/RHWXM>:8A-EQVS"@RLPS-EU3$U]QRNHBOV["]FO+6ZA$A6P5#KPM96\
M5?;.W;N-QK`.K]LXZ9:RMZ[SA"3G*5RS8=.J;?A*'.D:+FO$N;$UJ[&<<;&=
M5&E7S45]/E\K&A9]52+:8[)D)0[(=4I#+41DH2VTC=#<>&PVE2FVFF_LI2`=
MAZ[DDZT2[I;<R=>O7M6LQ<\EQDE:@JJW;\:*/C3DN9E[0<ZTXQE.<5)-/BU]
M(V:ZJ'ZNQCE]M33BIK`"'%(]Q"?B&O\`4905!&^_3NZ[CT&M8):=?T7<F.I)
MP]S.S2J:XN;\Z>1=\+D<K$DZIQ]W/Q]!8]A*[X,)9.Y5"B*)_28[9/[=>H'2
M6Y:5C2?-X]O]B)I5DI1R+B7)3E^EF3KL"2&@//M+*'35\VWLY3$&JJX,VSM)
M\E79'@5U?&7+F3)"]P$,1H[:EJ/U)T!28YHX7RCYAO$?S%/F9N-VSS.&<H8W
M4\$UO>[[+W#W&A_+<V<;9V[9#;>)S8,D;`);=9DG[Y.\"JA-*,8^@47^W<\B
MT8!Y&<B>.UK-+5#SKBC>28K'6Z#&;S_CV._*=::22$H?N<1ER-]B"M4-L;'1
M'"\TZ4+F0W^GU^GJ#M^C<=#MJ)(#0!H"OW_<;?\`DOXS^H^0N,I4G_*I)Q#,
M=TJ'H0=&3['-C"_[:PD\W^4P^KBO`-NG78Y;9@C?ZCMJ".=[V?R\BWQJ)2E=
M7^Y'IJN1XK\&7SS;1N*?GYJ'5K6E)>^!N<%R7\Z:;4?M!A:ZYEUP>BBTDGT&
M@(YO[<6ZO(GF#S!0Q%R?Z>N>`9=A?,I*Q$^.I,ZQL44E\?Z:'VU6DIMM1&_:
MXI(Z$C0%T(D]O<DI!V!^\.T>G<._8#8=>N@*%7SD/.ZT\MO).[P?&KA]S@7@
M>ZM,7P:NAR%J@93EE>XJJR_/W$MD,39,ZQ0]!KEJ"@S!:[D;%]9(CTR\F6;O
MD\^#]7XA^+>.WV0U#*.;N;JVIS_DFT=91^8T\"P9$_%>/VGU$NLUV,U<D%]L
M=J7;!]]:DD]O:($M'[R?\2=R3]9)T`:`-AN#MU2=P?\`V]=`1E>'GA-D?B=Y
M9>:><XN,7@>/'D3/P+-<&QRLEOBYQS-X2;M[,JYZE$-J%640G7;RX9:>7]EQ
M*2E(2``)-=`&@(R?FZ^3\CQ<\(^3+K'Y*FN1>4VD\-<:,,+VG*R3.X\B#,L8
M2$@N%RFQY$N0A202'TM#H2-`5"OF+^!-IX2-^+;,M$XL<K\`8_99B_,[W$Q.
M8J<`\ATJ'7%]K*8[5W7^RT!MVH6?7N)`MI?)C\C5>0_@EQJFVGF9FG#"Y/"V
M8>Z\EV6X<.;8&*V<D`!8-EALN`2M7WWFW#N=`2LZ`YM_?3^O0&;H""7GZ.AW
MR+Y6)[1OE#7W_113456X`V/<0/H&O/!\3L9Y/Q/;KMV7!7(ZK'CTU?\`R]CT
M5-MMCWX_Y-P87/85A_MR%AXVNY]='AQU)BVU:.P*J+E@V4!P$_:[$R%?$PUA
M(^RIM8Z^HZ#6PO:37M3T>S;M9:M9>$XQ<K=RTY2I#C]U6/!NO&E/`MG7\3%R
MG.&+<4+_`!XUH.Q8O,#Q?&;OD2OJ+*CL\7KOC55K4N4Y7S)4E]J'#BHD.C94
M>7,=0@H)[DIWWZ:W0AKFQ-L['O=S=/P\W"U?2[-R5N$NI6[MUQK&%&Z=,FDJ
M&+I_CLO,AHV1<5ZW<FHUYN*;I7UH2##["TS.T7D&23%V-E.?]]Y;ZE+;8#BB
MM,6$@_8:B,)(2VD`%*1L2?76$=JZMJV_]>_Q;5KWXG(R7U*4VFK,7^JF^5/(
MN+.L1T/">-C\.`[&%CM>*U$IIPL/,)"T>VL)<;6G[2"VXG92.TCH-R-;::;M
M+3--T9Y>'>4LF"ZHNO%T_A+&>5*]]6?/Q/&O'<:OJE=UERK.Q>IE*I_@J_O2
MB6ZM9>CR70RA1B*>00%+[DIV3U.J37Y[>W'H*U3<4+^9?QNI*U9JYRX+@VO5
MYDFW:OV+J5AJ$)/BV-"Y`R)U]J3#HH%;B]:Z'4+CUB`F=*`W2!/MG_\`?WE*
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M+EW6QI,!?%LFCY+C>TTENWR'/*V9)Y`4_P!%(=[["Y?90HCHTTGZAH"ANXK-
MO`3S5?$=4AC+/%[G57M)4%I5<4^.78"$J4@)#L7*,+DC[)Z+3)(^@:`^CQA>
M74?(.'8KGN+S$66-9ICE+E5!.9(4W*I[^NBVE<^"DD)[HDM.^_4$$>HT!LN@
M#0%?O^XW_P#)?QG_`.H;&/\`PCF6C)]CFQAG]M4E1YO\ISM]G_A7Q\"=E$]R
MLNN-AL$]?LM[G;T!&H(YWO97Y>!;QDR(\*,_,FOLPXD9IQZ1*E.(BQV&FDE;
MCCS\E3+33:$`DJ4H)`'KJ)2E.SYW_EI3^9/,?#GB#XP_$<SKX[R"UNKU[C]A
MS(XV4<GW49-#5XWCCU69#=NSB]0Y(^,F-GX-MV2M*G/Y2B`)C/D^_+EL/!WB
MC(<KY0,*3S_S"BGF9I#AO-3(6"X[6I=E4N`0YS0]N7+8F2%RK1]LJ:<EJ2VV
M5-LH40'V>;/*4OA'Q$\D.4JYWX:UPWA[-[&EDE1:]BZD4KM=324J204K9M+!
MI2=NI4G0Y059KUGSW/#[C=KF3RI\;.+[!MV;!S;F/`*J_2\0Z[+K_P`_B3[T
M/*7N%JE5\!U3A5T/<HGU.H%;6G$^F&$(:"6FDH0TTE+;2&TA*$--@(;0A*=D
MI0A```'T#42A?/CS/W0@&@#0!H`T!Q5]TG8G8;[#<$]OVNFW7?I_CZ:`KC^2
M\P>>'SE.`O%V*H6_#7A7"7S!RFVTXI^K?SN(BHR)4*S:`+*U-S_R&J`7]T/2
MT?Q[`.:^>QX]JYL\%<FS6MA"5F'CY?0N6:U;3)<D_P!-LH<H,]B1T=JE):-!
M8&6KT!^!2OU&@(5_[>;R+''?E!G7C]<V/L8US_BAL*!E<A(95R/QTB1-A)CA
MP^W[MOA[\UDE/5U49L'J!H"Z..@`WWV^D_2?I/\`B=`=C?WT_KT!FZ`@WYQL
M)$3R+Y4]OV-D94T4>_&C/I!<IZH+Z/M+"@1]>^O/?\1.KYVF?%+NR>&[<9+5
M8\[=N?\`Y>Q]N+-K=J6X?Y(P'XNP_P!N8LW'F?W\)N*W&11J.R?;0<9HGG7%
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M5</U;KL=;?D^MEZ;>TS3I]$DNOBN/O)?HZJ##<YN9$R?_-%>%.RF`Y[%?7QS
ML9#7H&&&^W?;Z-?-W?&N:CJ&OQGE2MRE[ZSRMVX_KR^S%&7].P\:&E-QC_W<
M_%^7K+`$#I`@#Z!"B;?J^';V_9KTG:6ZZ9C-\WCV_P!A&GUY)7II<NI_I,O5
M<2C]'7IL%?H/H?T:`J*^;G,?(_E'\V;%J_AS@K+?*?"?`J16R)O&&'V,2N9N
M<KJK&+/R2XM+2<U)K8\*-G#T"$I12XM[\M*4IV[M@)03\Q7YAA)/_P#(#FC?
MJ=O^*^-*)]?11H4@=WT#IMOMH"M=\VF/SEGG/4+R.Y=\1\Y\3T\HT57CBZC*
M[VJR.'EN583#+4FZ@651&AMM3_R"7#2\RX@+)8]P%1[R`+'/R$?(_P#XR>%4
M;C"VL%3,N\<<E>P"6AU8<D+PNW]V_P`$F+25=ZF&8;[\%*AT3\%M]!T!.!H`
MT!7[_N-__)?QG_ZAL8_\(YEHR?8YLA2^3/XATOESR9SE0V_,/-7#KV$X)B5S
M77'"6:.X9<3W+C(9\!V/>/M1GV["#'3'0MIM?W%[J_7`F772-/,SOFP>%?E)
MX<3\<M+SR.YMYX\=,^ER*2AR;,\XRN5,H,E$9V2,/SBI1>/U#LB7$CJD5LIM
M#;4U+2VRAMQ"DJB4A(Q_;N<^<&RZ#,/'F7@&!X?Y!48GY/2Y[!I8$7*.6./Y
M#ZGIT";=NMJL'KS"9,@(7%:<2TNM<:=".YMU0`M%``=!L-MAL/HZ#8?[-`,$
M^:ACLW*?EW>7517(<>FGA^XMD-M[E:VL<F5]_)0!U'6-6*Z>FWKH<[?MKUE(
M'Y;U_`QKSW\0+N<\AFN3SIA<"1([B$H-S*72P5K4X>U/NS+!`4=P/MD?5J!5
MRXQ:]!]'KKZ$`$="!U`(Z';]&HE'+C)L-#B&@#0!H`T`C/D-S/CWCKP=ROS?
ME3K0IN,L(O<L6R\M*/S"?!AK-/3-J'W7KBW<8BM?YBMX;:`JF?*WY=\R>)FN
M;_*+&_`#E+RCOO*W+I.2+Y<J<KJ\6J_RJNO[^3<T=.U909TF=$_K*;*[WAV(
M_P!T;;3N&M]`2GY;YV^>F;8GDV%Y%\G3F2QH,NQ^WQB]@+Y6QE(FT]Y6R*FQ
MBEQ="=@[!E+3OT]?4'KH"G=CMMR1X<>2-!D-AC5Y@W)GC]R?1W4O$KP]EU52
M,=L8MC_3UD&"AITV>/.B,ZXT2T^W(+@W"QL!]*SC[.,?Y-P3"^1L4E(FXUGF
M+4.7T,EMQ#@=JLAK(]K"*E-E2?<2Q("5CZ%)(^C0&Y-_?3^O0&;H"!?R(DM1
M_([E5;JGVT)R5HJ$=2/<<4*BK.X]U*T).W3T.O.S\4%V%CXFMV7_`&JZQ&+2
MYK^[X_%^CB;:[1M.YL?3U%JON'^W,4'CKD.33-M#'V(-*X4)2NQ;8:F78'4+
M6BSF(<5%[M^H90C?Z]97[7]S[FD:;<AI4X8]QJ,)3N)2DVJ]/NZ)M.KX_F+>
MW!HD<BW%7W5)NBX^CF/#X^NF(*6<YS2QG2A[CO\`3U?*D2')U[.&R7;!N,X\
MI28,??M+J_Y9]0"!MK>?M[J=C3E;WMO3,R;THV&[6-<G65R:JXN,:]-*T24O
MSF+];L=3A@XD.EKA*5."^3Q_C-/R_P`=\(S1,/D&ANU<96^863I-7$B_F^.S
MYSTCVDSORWW(S]<Z[M_.4PXE"E'N(U8'<7X:-B=P+5GN#MW*6W-SZI?Z;5NR
MY*S>=5QNP5:NKH^E>H[/1=[:GIEB6F9$97\6'-UI*GDJKC^>AZN*>-D*JN9M
M7E6=NY1.I8`LCCD""NHA3>Y)<2P_,><ES'67`D!Q#91LA7KKL]B?#+CZ#JEW
M%W7KBU'5\*SUPLV'.,)3C673)32;\*E/JF\87[$5IMBY:A-TK)IOUT7TFZY!
M<566TL=6,!=+D^.P0T,>A/KC?&U41*5+%.AOM]QR"=U)2"'.U)'78:R+NO<F
MF;QTR$]!E>TW<6!!P=JU-0]YT_82?36-*RZN::H=;;Q'@Y7_`%%*_&ZDU)?J
MOTU\_0-*S;DFWFQ%Q+E]C(8;:'$H1;ME<YH;$$1;-/MV</?;JGW%)/TIUI?W
M2[L:[<T^>F:ZK>79MIQZY12OQ=/%\*OT\49(TC1<).&3C]::DI47*J\T,YR:
M9$ESVG(P>;"IL<EAYU,CVO\`>&NB)`0TM:=^FRD[CZSK1G5]3LZGK49VXN%;
MMFB=/MOAP,I8MAVM+N*37W=J3?IJO`L4UV_Y=7[@@_`0NA_1&:UZ=]+5-,QD
MN/W%O]A&EV2J9$US^N_TF9JN)(V'S,\AZKQ6\8^9.<[)UI,O"</GKQB(ZI*?
MS7-+=L56'5;(6"'5S+^:P%)`)#:5$]!H"*#^W[X%M,;\=.1?*'-D.RL_\GL\
MM+%FXG(*I\C#<:L[%@STO+)<4,CS&;:35$_Z@#1^Z!H"?P#8;?\`+O\`M.@(
ME_G6^.A\@/`SDB=5P3+S#A&1%YGQDLM]\U<;%VI#680(Y`*NR9B,R6M2!]];
M*!Z[:`K>?(<\C!PEYMU''MM/#&(^1F/R>.I0>=[(PR^*M[(<!EMMDA"I$B7%
MDP4*/VA^8!/TC0%ZI*@H`@$;@'J-O4>A^HCZ1H#EH"OW_<;_`/DOXS_]0V,?
M^$<RT9/L<V,*_MJ__P`W^4__`.J^/_\`Q;::@CG=Y+\O`L_^3GCW@7E1P9R%
MP/R/&2YCV>4;T)BP2VA<S'+^-M+QW**EQ8)8M:"X99D-%)!4$*0?L*4#$I3Y
MY5O"YU\`/*J1#$E_$>;O'?D)#L25LM%7<KA._$0I@3]E$["\ZQV2A13]IMR)
M+[3]H=(5)L;3DJU7$^@9X;>4N"^8_C]@O.>".-1V<B@?`Y/C0<]V=A>;U*4Q
M\HQ.Q225MO5]EW%A2]O?B.-.CHL:B<)1<'1C@,QQ6GSO$,JPC(H_Q-!F6-WF
M+7<5:0??J<@K)558-*2=Q]J++4/T:$$Z-,^:7S3Q;R!XB^1>7\8V@>J\\X,Y
M(+E%-=<4P)S>/V[%W@^3PWMDEZ%<P6H<YIQ(V)<*?\JMH4*CW\?)GT6/%SR`
MQ?RAX`XJYUQ&2Q(KN0L4KK2PC,*"E4>2M-")E&.S6PI:XTVCOV'XRVU?:'8#
MZ$$Q*=T;X<A?]"`:`-`-,YX\PN.N!>7O&W@RYJK[)^1_)O/)&'8A1XX:];M#
M4U\;XBXSK)4S)3#D?%ZQ:D-J6VE;CCA4$)/8LI`=G])&X/\`CUV^LCZ-]`5N
MO[@'G"]R.J\??`CC%YZ7G?D#G-+D&45M?W&4JF8N6\>P&HDI;4=F+[-))E+"
MA_IU6_W3H">K@7B2AX$X7XOX5QAIEJCXPP?',.AEE/;\4]45S+-A9.GM1WR+
M6Q]V0ZHC=;CJE'J3H!6SU!&Q.X(V`W)_0!^G0%+_`/N'O'G^@/)_`?("GKPS
M1<]8:FER!]#38CKY%XV::KW$N*2D`2+;$94%8)^TLQ7%?0="9"VYUHR7+Y`/
MD4GEGPR?XBMYQDY5XXY.]B+:'G"Y)5@64_$Y+@[RRL^XMN*'IL%!]$)B)1H)
MVW#F3HM_?3^O0EF;H"!_S"H)>/>0>;/2&U!F^569'`>*5`/,2JZ-%5V;CM7[
M4R$M!VW`VZZ\^_QH[7S-L?$7JVI7H7%CZQ=61!N+49?=0M_5;24N,/"IM9VR
MR[>;M[&QNI4M0<6FUP:E+Y.8EF'Y&S72D29B@^VRD*1!5ND2W=_L(=<1LIJ,
ME0W61]H]`/4D8/V5K^-HFH1OZC&4W9:G;CQZ93;XI^?31.GI+AU7"=Z;5N+E
M%5XKC\XXRHSFPR&>PJ3*+\N68T&*@+#3+2%+2S&BQVD]J&(S2U@=J1T]22KK
MK:[;'<K*W3G6\?4;E=1E*,(13^I"+X*E.%461J&@0]W.XXOK46^3YBYWW(\>
M39P(]<^?RG&&(M/5EMQ*4OJ@NLJES>Q.P4J9-;4OZ=T``]-;%;K[CXVK9^/;
MTJ?NL+2968XZK1.Y6LWSXU:1:]C;CC@W;]R#][*KY/Y%ZE1'NYAR<_4<GV5_
M!?*E5UFPCV_=3V2([49GXB,>O;V26G%(W_2/JUWV\^Z-K1>Z65K6EW*V;-^/
M4JU4T[=NM%X^)18NVHWM,MQG!INTV^#33J_G$:S[+(];>2GZR:M$9]YF[HYB
M%K#K<:9M8PE(6@]S2V2X&U?4MM0_1K`?</N)9T+6I9NF7'&-R;ORG%U]NB4%
M2J;73]9+E55YERZ1I+S,./XBV_>UZ76+35*<:-<GX#;LYSC\\6]/=*&K)Y;I
MFH9[0S.<4238-I&P;?5U]U`V"U?;&W4'4ON/W!6YI7=43A;U!6Y=<*I0E"G&
M7.G73PY\N!D#2]&>!;]WTN2GPX*M*B9XS3V&79=CE'`;<?EWE]4P&&FTE2S\
M3-92XX-@1V,L%3BOT)^K5H[)T&_NC?.F:;CQE.=_4K$7&*<GT=4:RHJ_557Q
MY'<ZM<A@:/E7)M1A&Q+B^')/AQ+(D=/ML,M@@AIIMH%/H4M(#:2-_K2G7IVP
M;#QL*SCOG"S"/R12-(7<5UNY%UC)M_.<UK0TVX\ZI+;3:%+6ZM:&VFPD%16Z
MXLA"&T@'<D]-51`IX?/S\]L1YGN<5\2N'LMK\AP[CZZ>R[ES)Z&6W-H[#-F&
M5P*'%X-A%6]'L48I$EORIBVBMOXMY"!W*95L!:9\7*?CS'?&_A#'^)K6GN^.
M,?XOPFHQ6WHI3$NNL:Z#CT%HSP]'6XCXB8^%NOA1#B7UK"P%;C0"\:`\C(8=
M+/H+B#DOP/\`3=A56,&]-F\U'KET\V$_&LDRWGU)81&7"=7WE9[`G??0'S)L
MP<1PQS]D[_%N11Y[/$W,=[(XWRJO?]Z)+:PG-I3V*VD66V?YT5]%8PKN22E:
M/0D;:`^@=X+^=7#WFYQ-09CAF34\7D%NJ@M\C\82K"*QE6'Y0U&:;MD*IW'$
M3)-%(F!2X<QM*V'FE)'<%A20`^/M4=QU3MU)(Z)`ZDG?8#IH"L[_`'&G-W&\
MC@_B/@NMRZBMN2W^6X^<6&,5=A%L;*CQB@QJ^A*LKR-#===K&Y\^W99CH>#;
MCQ"E(':DZ,G66DW48E_;R<T<<<8^3/,>(<@Y538A8\J\;4%;A,G(+&/55UU>
MXWDCTZ901YTU3,5-G(@S"Y';4L%\ME""I9`,$3+K3CP:+IB>UYM#C:@XTL=[
M;K*PI"@I)`6AQLE*@4GH0=1*4KJ_/P\#_P#BWQA%\O>,Z;WN1N&*E$#E"%!C
M]\O+.)42%/*N"EE(=EVO'TEXR.X]ZE5;TA/_`$*!HRIMR25&^!"!\I/YAP\&
M>;)E3G]A,/COR^8D'D6-':?F_P!*7\9L1\?Y*A0V4N+=%>UW1K)+8[Y$)05]
MI;*!J".-YITH7M./^2./N6,:K\NXSS?%L^QBVBM28-[B5Y7W<!]I]E#J=WJ^
M0Z6'T(<'>VL(=;5T4E)Z:B2"'[YN_P`K1/FEC4+F#AABLK/)+`J-=3'BRE-P
M*KEG$(I<D-XE:V/1,2^KE.N*JI;N[8*U1W2&E)4V!`Q\L_YA^=_+1Y;RW@/R
M+QC,ZGAV^R%9S[#+:KF1LRXAS)I+<!S-:6@G*$F546+$<-V<5DE,I#:)$<K<
M0H.`77>+N5>..:<.J^0>*,XQOD+#;MAN36W^+VD:T@N(<;2X&WO8/O09:$J_
MF1Y"&WVE;I6D$:`4/M)]`3TW]#Z?7^K0#//+[SC\?/"K")>7<PYK!8NS%?5C
M'&U/*BS\^S:Q#7N1:ZGHD+5(CL/J&SDZ3[,.,DE2UD@)(%;_`.69S%R)\P_Y
MO,_R>Y199:1QEQ?FV28MBD=U<FFX\QYY(P7"L7JEJ"/=>CC*IDN1)6E#DN8X
MXYV@;``6N^6^7>.>#L%ON2^5\PI,(PS'8$FRL[J]L&(;89ALE]4:OCO+#ME8
MRD([&(T=*WGG5)2A))T!4"\,/(3$_-KYVM5Y"<LV,+'J)W^LK+A7'LGF-0FX
M0P^@<Q_BO'6W)#R(7Y^8<Y^T+:2E3ECWI2%**1H"Z+VE/7Z%=0=]P?3[IW(V
MV^KIH#B0%`I/4*':1]?=]G;IUZ[Z`A0^?QB>#9#X!9#<Y1;4U7EF!Y_@V4<;
MLSYC$:RN;Z3:IQNVHZA@J^)FN3<:NY2UMM()"6`HE*4$@R=9='QY%:'Y37F[
M5^$'E#&R;.Y4AKASE"C5@7*3\=I^4K'XQEIL<8S-,%I)=E-8S;]_QGMI+HA2
M7B@$@#4$3;CBX/BJE^C!LWQ#D;'JK,,#RC'\RQ:ZBLSJK(,8MH5U4SHLA)<9
M=9FP776B5-D=R3LI*MP0""!$I#=M`-1\G/'B)SC1,/5K\:MSC'0^O'[&3W?"
MS8[_`&+DTEGVH6I$62X@*;=`)9=2#Z%6M3OBI^&_$^(#:\;&'>AC;PPDY8UR
MM*KGTR?IE7T(O79&\Y[4U1/(7O,"XUU1\EY^OT>)"]EV$9IQQ:R*K,L=LL=G
M1UK0')\=P09(0LA+T&Q0A4*:PX-E!3:SL#UV/37PZW[VOW=VZU5Z;NS`RK%Z
MPW%77&;MW6O:<'&J=%1OT-&T&%KVD:VGD:=<C*RXIT4DJ?.CHI,M=J9#<DO*
M]UIMWV>U:/Y3[B"VAT$D[AH'N&W7NVUT&@[@N:+=6;8C<C?33BW&[P:Y/\Q.
MN:?:OP<O1]M?2;7'SMSL0!)V(4`DDD_:43NI73ZSUU<>)W"UFW*"R+]*WE+V
M+GFO04^1HUK\+Q\OMKZ3V+[D5<VSL92I0<5(?][[VX(]EM('78;_`&==[N#N
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M!<W!=>FZ:^G3X^T^*4^/Z.`_X=-O3I_LVWZ=-?0^G3P,21Z.E>[5(>"&4^7G
M@GQCYI_T=&Y1Y!YRQFDQ"-<11C7%?)4_!:')47+D);R\K@0XLA%RY&$%*6/<
MZ-H4H;'??0Y#+&/D!_+H8C^S_2?*SJP-S)<Y9OT/N.?2ZL,,M,)<)ZGM;`W^
MC0"K\!_*#\:/&?D[$.3N(L^\D:-S#;=ZYA8+)YFMI?'-K(>A2H/P^0XJF`Q#
MMX+:9BG`VYU+J4E2CMH"5)2004_01MZ;[[=?0GT)'^&@(W?*+Y7G!GEYR19\
MB\M<E^1K*+>FI*65@>&\NV.-\=-L4C"F$/QL5;@RH34FP0K>6KK[ZNIVT`W>
M)\@'Y<\5E+*L5Y8EJ3L4R9'+%\V^-O1(1"9B1@E(Z`!&VV@,-?R`O`V'8MW&
M*3O('!K9A)$6RQ7F"?`GPU?Y7(L]RK?GM%"ME]H="5+2DD=!H![?+'@I@',7
MCSQOXVY+RIY`5N)<:KIE1,NQSE2UJ>2LM135<^J0QG67ML*EY%'FM6"G'T.)
M`6^VVL_=`T`R6#_;]_+VCN.R;2!S;DTU]14_+O>6[-4A]9W'N//5U=`6\YM]
M*^X[_3H#G/\`[?SY=4Z.6&L:Y<K5]P4F3!Y9N52$K2>Y"PJ?#FMI4VL`C9/0
MZ`>)XA_+XXE\++C+K/BWD+G;)(.7T]=2R,8Y1Y-L,WQ>G8KYRIXET%1+C1F*
MRQE+66W'D]2S]@`#0#Y)\&'9P)M78Q(TZNL8<FOGP)C29$2;!F,+C2X<EAP%
M#T:1'<4A:%`A220=`0JL_P!O[\O1%G:64BFY=E-V-E/L&:4<G2X%+4M3I3LE
M%95L5M7$DM5]>ET,QTK<6I#+:022"2!L>+?(R\,N/<GI\KXRRCR3XVL:BZK+
MM#.'<WWE9#F/5MA'L?AK%`AJ?G1)CD9*'D+</>VI22>N@)DMAN2-]U$E0_R]
MQ)Z@;]-QZ_JT`U;R2\)_&+RVK6X///$N-9E.BMJ1596VR[1YS1DI[4JJ<QIG
M(=ZPA(_Z);KC'_,.@(KX7R&\>XJR*5DWB=YK^3'CC,D.E\PZVP@W\)2@7%MM
MRC`D8HY8(;6O8&2'E]N^Y))W`49SY9OG+D##M7F7S>?(9ZD<:+*V<9PNKH;-
MYI2>QQ+MG&R1I[O4@G974A77KH#7\7_M_/#X6TG).8>0_(3G?)IY0JQN,TY"
M,!ZQ4D]ROBY-/"9N7&U*ZA/QO0D_7H"1WQN\%?%3Q%L+ZX\>^)*SC^\RFKA4
MV27C5UDMU;7=96S#/A1)TJ^N+):FFIBBX0CV]ST.XZ:`:/R[\F#Q1Y[Y(RCD
MSF+,_(_.[#*<HMLJ<QRXYGMGL0HY-M)7)768U3*KU)I::%W!N.RRM*FF@`%_
M9&@$_G_("^7?+8#<2AY@I9""E<>=5<M73<R(XCJAR,[*C2@TM"NH(`(/7UT`
M_?Q)\.,"\.,?R_&>/\]YES>IR^VJ[537+_(EAR`YCHJ8#L%BMQ=<Z/&345SH
M>4MY"$[NN=I5]T:`=)=U;=Y2W%(])FPV;FKL*EZ76RG(5C%:L8CT-V37S6MG
M8DYAMXJ9=3]IMP!0ZC0$,5A\A7POR65%G\@9SY1\DSHB'4-2LWYRM;Q]"7@I
M*_;?EU:Y#!4@[$MK0I1W).YT!F+^03\NA3);1B'*C"B@)2ZSRUD8<;(VV6V5
MI6@*&W3=)'Z-`*/X^_)R\7O&3E3#^5.'LY\C<=GXC>*O$XFOEV:_@F0OJBRH
MAB91CC57&8N:]:9:EJ:=42IQ*%%7V=`2VZ`P'4I*G`1N%$@_I!&Q_9J#C%^"
MJ_'Q^7F2_=6W6J]KF8$NLK;!HL3X$.>P1VEB;&9EL$?469"'&C_B-=9J&AZ)
MJT%;U7#Q,J$:T]]9MW*5YTZXRI7Q\RIL7[^-'IQYS@OY,FOG3JS7U<?8"LE2
ML&P]1/J3C5/U_6/@]CKI7V_V(THO1=):3K_RF/\`V96+5]5BJ+)OI?O)?2`X
M_P`!&VV#8>-O3_NS3;#_`.BU"YV^V%>:=S1-);7+^YX_]F1>LZO)=+RLAQ\O
M>2^D_3@&!'??!\/Z^O\`W9IO_L]<_P#(.Q%_])I'_L\?^S.*U;58JBR<A+]Y
M+Z3B./<`!!&#8=N/3_NU3G_WP]'L+8K5'HFD4?\`Z/&_LR+U?56J/)OT_>2^
MD]FOH:*H2I-124]2E?WQ65L.O[MSO]KX1EHG78X&V=MZ4^K3-.P,>2_\+'M0
M_9@BDOY&3E0=O(NW9P?@YR^D]7;;_P")UW:=.1(:4HJ#]E<OX^9^Z<R(?5^D
M@#])/H!^DZ`1[-.>>+<%GL4MME4*9D<F=&K(^,4!%WD"ITQ]$5AAZ#!4Z8;B
MGE@;/EO;?0"P)[NI(4!OTW2!MT'<"/O!05]'IMZ'0'[L3T'J?3IOU^CIN-`:
MS39GB.16=Q34.34EQ;8^ZF/>5==819<RJ>6M24HFM,..*;5W@H)]`L=OKH#9
MM`&@#?;J>@T`?1O]'KO]&P]3_AH`T!UO/-1VG'WW6V&&6UNO//.)::::;25N
M.NN+*4-MMI!*E$@`=3H!)JOG/C2_SJ'QSC>2QLER63'L)CJ<>0;:NKXE:VAZ
M0_96\<FO82HNI;1V+<)60#L3H!7=`&@#0!H`T`:`-`&@#0!H`T`:`-`&@.;?
MWT_KT!FZ`PG/OJ_7H#AH`T`:`-`&@#0!H`T``_:2D;$J5T!^M*5*&WT`[@==
M`1N8[4TG,'FODF60X-:UBW#L-E4J9&BQF6+3)(7Q,&-+E/I;;$ETV<B0XE;A
M40F*#W>F@)'(\N-,0'H<B-*CKW4A^*\F0TM?<4._SFRIHJ#B3T!]-`=Q4$I*
MRM*.S=:E*VV0E&RBM>^R4-[?YB0!H!#^,>#>...<IR_.L+,IZ=FRWS,>5:IL
MJZ,AZP=L)<:K]IM*`T[8K+BBM;CB5#M&PZ:`7$;_`/-'57T[=`-]P-MU=>AV
MWVT!AQ["#+]_X29%EF,OVY(B28\HQG1OW-R!'=<]E:=NH5UT!F$#Z?N[;G<;
M?9VW/3]6@&ZYOY`1,3YEPCAN#0IM[')(Z;*YMW[=JKB8K6J3)<;D.H=C/)E/
MB-%6Z4E38V*0#NK0#@F9,>0TT_&>9D1WDA33[#S;K3@*NW=+B%J0LA7KVJ)T
M!UV+\.-`G2;'L-?&B2I$\/(2Y'^!8CN.2_B$.!3:V@PD[I4.HT!'MX3U$*]R
M3F7FU<*'3UMW?2*7'D!B/`KH=9)G+N)J80`:8CLI;=BM*V`'<D@:`D/8D1Y3
M2)$20Q*CN`EJ1&>;?8<`4I*O;=96MM02I.QV/KH#N/3Z"?T)&Y_P'3?0'2_(
M9BL/2I+S,:+&2MR1)DNML,,M('<MYUU:@VTVD>I64@:`Z*^Q@6L1J?63H5E"
M?[O:F5TMB=$=[%*0LM28ZULN(0M!"B#]E0V]=`=S\J)%4RF3*CQS)<]F,'G4
M-&0]MO[3`=*/=7V^@3N3H#B9<5,AN&N3'1-="U,Q%O-HD/H;`4M<=EQ2'7TI
M2=U%*2$_2=`91&PWW'JD`;[G[7;MND;D$J5V@>I.@,9J7%?=<9CR6)"V%%$E
M+#S3RXSFW1I]ME:W&G"?H(&PZZ`ZXL^'-][X27$EF.Y[3PA269?MN=3V+]E:
MNQS9)^R>O0_5H#]CSX<M;[<65%DKC.>U)3&DL2#&=W/\N0&EJ4PM0'0*`)T!
MEZ`!U(`WZ[_0K?<';T[=@DGT)(!^O0'FP+FGM7)C-7:UMD]7/"/8-0)\28Y!
M?5W=K,M$9YU49TEM0[5A))2?J.@/2T!S;^^G]>@,W0&$Y]]7Z]`<-`&@#0!H
M`T`:`-`&@$MYISYKC'C#,,S6I`D5E0^U5I6=O=NY^T*H:'KT,UY*E?\`-23Z
M`Z`8)XS<'W.;\5VUGG5W=8IQ]DLVPR.T332S59#G3L9MQ#5E;V2DK>C8I41D
M.>Q&`VE/.+=5LGM&@%H\"($Z)Q=ED@+DJQR9GME_2QDK4>^!#BQXTAYEH@);
M:=D)W.P`4L*.V@,WS(O;:DP.]D6UTY`Q>5"8I,9QZEFR(=WEN:VO>DKMY<?V
MW6L<QVM;4\(K2B93Y'O*[`$$!6/&#CR9QEPMB>/VCF]O-1)R.TC_`&NV%+OU
MHGB"T%;%"8T=:$J&P_F=V@$3YDS?)>6>:JCQIPBXFTE+':%ERED%1(7#LS6L
MLMS9=)$F-'OCLM0WVFU]J@79+Z4G9*%#0'B9='H>(/*+@+$^+ZN)CL2YJGZ?
M+J>MW:1;UEC+D1X\V[3W+^/G14,./ID.=S^X.ZR#H!^5]^8FELC33JZNL!#4
M85E91G9D&'VM[N3),5EUE<A,9(*NWO2E1`!.V^@(S?'+CJI\A>1.7N1^34N\
M@4L2:UB]+*N6Q7-V;RB4_&HBU"HT>,(E0VV&VT;I;#X!*E)*M`;?X1S9U;GW
M.N!P)<M[!\<N5JHHC\MR2S726[^WJD,QBY]T2H,%)7ML%J03MON=`+YY?9R<
M&X*RQ;#WLV.3I9Q&O^V4'_ME2F[!SH00EBL:>)(V[=_70"%<(\%KRWA.D3R0
M]:T^!1*"QMZ3#*RQD57YG+L!,G2\[RMR,&9,MYW=(K(:U!EB*RA:P5J.@/8^
M7Q^;GC',?B),N10(S0LXXB2I:FF$-UK!L4Q0LD(0MU;96E("0YOTWWT`YCE7
MD]>%JH\6QJN:R7DK.'G(.'8V5K1''LE1GY#?.I2HP<=HV@7'U_>=["A'4G8!
MFGE90RZ?&<3PZ7F&49ES3R?D4&N2XW<V,#'V:IYU$:TB0\1KY+55$QQV>^AA
MIMYI]]24*4IPE)V`?MQS@]3QM@^,833MM-PL>J8D%3K2$H$R6$=TZ<H)3LIR
M=+=<<)V]5Z`C`\HV<@?Y?XTH;.?(RSDJ78MY`[3TT^>Q0U,.9>QF,,Q7'8"D
MH3#46JXN3)SH^(>4\M2MFPD)`=M`\5$RN0,,Y:RSD')Y_(%39?G63*8]E539
M3R"\Q4TB''`]18]5E9CI9;"_?:2"O96YT`MW+DFWB8J_*B7K&*8_&;F6F<Y(
MVHBZJL8@Q')4YC'-T+9%Q:*0(R'UD?#)<*T@J[1H"-?Q2Q*SRQ/+.6RYMOA7
M$\V0N3EEE%M9C5O9UU2N?:M8M&NU/F:T1%DH<LYJ%%];80PE8+A4`,/Q9QVS
MR?(.7K?'K*UP/@]XN2,EMFI\IFU_((4F7<PZ&NM'%!UFSDUB@J;.W,AB(2D*
M"W0=`+?X,XFT[?<M<GT+4ZIX_O+=['<-IY,N7*4_$A3WI_QLMZ4?<EO08[C+
M*75;N*6MSN)VT`]_D3D''N,L4L<LR20I$.(6H\:)'0'K&WLY1[:^FJ8_<%2+
M*R=(2VD#8#=1^R#H!J_*[U[5\3Y+RGS1?W%5<RZJ1'P?CC&+V?156*6MFT\W
M1Q9<BKD1I62Y5%6M+\IY]9CLEE:$-A(W(&Z^'G&CO'W#\"RM6U_U3R#)5F.0
MOO$N2E":DBHC2'U?S'ELUY#BBK?^:\LCUT`ZK0'-O[Z?UZ`S=`83GWU?KT!P
MT`:`-`&@#0!H`T!^CJ0/K.@&`>>EFK\MXFQ:S=D0L-N\Q<EY59M^Y\.Q'@K@
MQ&?>+:3_`-7CSWWQW=-T`[';0&ZY+D#G.=%&XCX'4_"X]5'BU.9\GM07J^BJ
M\58;;9=QK#W)#3+US<V49/8I3:/9:0=U+.^@'3XEBM+A&-4V)8Y$3`I*"`Q7
M5\9!)(993U=>4>JY#ZR5K5_F4HZ`CEYARQGD?RRI,+L:JWOJ'B9A4RJPZLB/
MR',NS,,Q+)IB44MN1($%4N2Q[LJ26V&HD=PE1)VT!)#CQOE4U8YE`K!D?PS3
MMNFH#OY8W-65.*CQ%2/YZV(X/9WD_P`PI[^F^V@&'\9N8]Q%Y%>3.3\GW$/'
MC+$>XH9ERXF,JZH+>;)G.JH/>7[UH^VW$896U'[EA>R>WKH#V^#L%R?E'F.^
M\FLXJI=%4+0Y6\6X_:-+9L14M,J@1+N9#=23%;1`*BSN0IUUY:]@`-`+1Y3Y
MZKC_`(4S*SC22Q:W,<8I2#JGV["^2F,I]HH!7WQJY+SNX![5#0#?N%>0L1X>
M\:,>J\==3?\`*=ZFV57X/5)5*RV;G-M(>:CQYM.`W-AQ*]L,EUY]*&4LIW"M
MB-`+SXR<+2N'L#>9OWD/YQELI609?+96E\1;%X+6U5,/@'WVJ[WW.Y6Y"GE*
M4/70"*^1-:YS#Y"</<(GWW*"D3(SS,0AMT1EQE.J6VV\^D%GO76URF0E1`WE
M';0&WY%Y`T')U!FG$O#L&Z>Y$=>E\?P8,RE?@5]1$6':FVR9Z8VMV-!H:2`E
M[L#JFWEK[`E!*QH!Q/%/'=3Q5@>.X'2E;T:FB]LF>M`2Y:63ZO<L;1\C;N=F
M2RH@=2$!(^C0##\0YD9B^5/--A>8WE&39HA!P?C7&ZJN<EO,0:N:IEZ*IT[Q
MJ"+8AII]^8]V-^VI9W/T@)SQYD&6YGY0YGE.05PR[D[&OCZ7#<=B,R_Z<IKQ
MN5^3]]C/4SVU6)8;'6_(6^HI>F+4%-A;CB0`);HX?1!C_'/1W)+<1E4Z0PE3
M<5<AME*I;S*"5+;8+J5*2"20-M`1^^.>.N<N\[<I>1%XRXY5U5W*QOC],AIP
M)2IIE5?\:RB0C8*K*1I"1_"_*61U3H"0U1W*E$].I)/T`#<^GU#0#'_,;);F
M^9P?@'$4ON7_`"?=1%W*VFG"W$QJ++2TV7W2$LI8EV`]Q?7<-1E;@;C<#6/(
MI@<<<6<<^,G%\1UVXY!FPZ-:V&G'7GZIN6PJYLIS[20#(O+-X>\I:NC'>!TV
MT!X_DHBNX"\?<-X1Q!2X:\XG?EUU>);<"I$:*J-,R>SDN1VU.NR;B<\TCVFP
MM1BA24I(`&@'4<"54NEPF!20Z4T6%4]?`K,-:LHK\+)KQ*&UJN,LOH;X2(']
M063BG8\=Q*)"&T][G:5!(`;+Y)\A5M/Y-<)5.:L6;V`8I"&6I@P(4BR<L,FF
MKG1:R2FOCI4[8N5LB&R$I;2XM'>>@"B=`(YS[F%YR/SIQGCG(E;=X_@K8@W\
M#!68+MED$FLF.R51T65;%]U#F69,FN#*&0K:"AT)6I*N\Z`E'PJ3DDS'HDG+
M*J!16\A;[WY'7.%YJFKENJ%3629'^F_91("4)DJ;_E![N2@E(!T!MF@.;?WT
M_KT!FZ`PG/OJ_7H#AH`T`:`-`&@#0!H`T!ASJZOM(YB6D"#9Q"H+,6QB1YT<
MK3N4K+$IMULK3OT.VXT!WL,,16&HT5EF-&82$,QHS:&([2`-@AMAI*&D(2/0
M`;#0';H#"16UK<Q^Q;KH#5C*;2S)L&X<=N=):1]QI^8AM,AYM'T!2B!H#-_>
M3Z?23N2?K).@/-FTU/9NQG[*IJ[%Z&OOB/3Z^),=BK)!*HSDEEU;"BH`[H(Z
M]=`>C]E())"4I!)W(2A*1U)ZD)0E(_4`/T:`CC\D;VIYAY]X9X0K;B!+J*VY
M3=Y>XS,9<BHE?;?-:IQ#RF')C-1`<'MD]P6\!MN1H"0EBFIHTURPC5-8Q8K;
M2T[8,0(S4]QG8%#3LY#0E.H#?;NE2R-`>IZ_L_9Z?[-`=188+A=++:GE!(4\
MI"2\I*3NE"G2"XIM)]$D]OZ-`8[%;6Q79,B+7P8DB:ZEZ;(BQ&(S\UY.W:[,
M=9;0Y)<3MT*RHC0&<#L5$="K[QV'7Z/\-OH^K0&`W65K,M^P9KH+-A*"4RI[
M,1AJ=*2E'8D29B&TR)`2CH.]1T!^QZVNB/2Y,2!"BRIY2J?*C1F6)4Y2-^Q4
MR0TA#TE2`3L5J40#H#,``3V@;)[>W;Z.W;M[?T#;IH#@TTTPCVV&FF6]RKVV
M6T-([E'=2NQL)3W*/J=MSH#LT!U*896ZA]3+*GV^[VWU-(+S?>=U>VZ4]Z`H
M^NQ&@!3#"W$.K994\VDI;>4TV76DG;=+3I3[C:3MZ)(&@.B975UA\/\`F%=`
MG_"/)D1/C8<:5\)(1]Q^+[[:_AWD;=%(V(T!F?1L0"`2?M`*ZJ))ZJW/4G0&
M$_6ULF7'GR:Z!(G0TJ1$FOPXSTN(A6Q4F+)<:4]'2H@$A"AN1H`<K:UZ:U9/
M5\%VRCMJ9CV+D2.NPCM+W[VH\U39DL-J)W(2H#?0&8`!T'0?NZ:`_=`<V_OI
M_7H#-T!TJ^\?]#U_S?>_Q_3H#C^'T`?A]`'X?0!^'T`?A]`'X?0!^'T`?A]`
M'X?0!^'T`?A]`'X?0!^'T`?A]`>+D>WY!==WY%M^56&_Y[W_`)+M\(]O^;>W
M]O\`+=O]?;K[7=MH".9'P?QL7?\`_GCM\<S_`-7_`#[\Q^XK_JOM_:^/_@_1
MOH"2>NV_+:[;\OV^`B;?!]WP6WL(V^"[_M_";?Z>_7MVWT!F?A]`'X?0!^'T
M`?A]`'X?0!^'T`?A]`'X?0!^'T`?A]`'X?0!^'T`?A]`'X?0!^'T`?A]`'X?
40')/WA_H>O\`E^]_A^G0'=H#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
